ORAGENICS, INC. Repayments of Other Short-term Debt
ORAGENICS, INC. (OGEN) reported Repayments of Other Short-term Debt of $62.70 thousand for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherShortTermDebt · last filed 2013-08-12
- ORAGENICS, INC. repayments of other short-term debt for the quarter ending 2013-06-30 was $31.97K, a 11.89% decline year-over-year.
- ORAGENICS, INC. repayments of other short-term debt for the quarter ending 2013-03-31 was $30.73K, a 2.59% decline year-over-year.
- ORAGENICS, INC. repayments of other short-term debt for the quarter ending 2012-12-31 was $40.52K, a 20.90% decline year-over-year.
- ORAGENICS, INC. repayments of other short-term debt for the quarter ending 2012-09-30 was $31.68K, a 18.91% decline year-over-year.
- ORAGENICS, INC. repayments of other short-term debt for fiscal 2012 was $140.03K, a 18.85% decline from fiscal 2011.
- ORAGENICS, INC. repayments of other short-term debt for fiscal 2011 was $172.55K, a 60.79% increase from fiscal 2010.
- ORAGENICS, INC. repayments of other short-term debt for fiscal 2010 was $107.31K.
| Period end | Repayments of Other Short-term Debt 3 month | Repayments of Other Short-term Debt 6 month | Repayments of Other Short-term Debt 9 month | Repayments of Other Short-term Debt 12 month |
|---|---|---|---|---|
| 2013-06-30 | $31.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $62.70K 10-Q · filed 2013-08-12 | $103.22K derived: sum of 3 quarters · filed 2013-08-12 | $134.90K derived: sum of 4 quarters · filed 2013-08-12 |
| 2013-03-31 | $30.73K 10-Q · filed 2013-05-15 | $71.25K derived: sum of 2 quarters · filed 2013-05-15 | $102.93K derived: sum of 3 quarters · filed 2013-05-15 | $139.21K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-12-31 | $40.52K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | $72.19K derived: sum of 2 quarters · filed 2013-03-26 | $108.48K derived: sum of 3 quarters · filed 2013-08-12 | $140.03K 10-K · filed 2013-03-26 |
| 2012-09-30 | $31.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $67.96K derived: sum of 2 quarters · filed 2013-08-12 | $99.51K 10-Q · filed 2012-11-14 | $150.73K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-06-30 | $36.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $67.83K 10-Q · filed 2013-08-12 | $119.05K derived: sum of 3 quarters · filed 2013-08-12 | $158.12K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | $31.55K 10-Q · filed 2013-05-15 | $82.77K derived: sum of 2 quarters · filed 2013-05-15 | $121.83K derived: sum of 3 quarters · filed 2013-05-15 | $165.18K derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $51.22K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | $90.28K derived: sum of 2 quarters · filed 2013-03-26 | $133.63K derived: sum of 3 quarters · filed 2013-03-26 | $172.55K 10-K · filed 2013-03-26 |
| 2011-09-30 | $39.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $82.41K derived: sum of 2 quarters · filed 2012-11-14 | $121.33K 10-Q · filed 2012-11-14 | $136.11K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $43.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $82.27K 10-Q · filed 2012-08-10 | $97.04K derived: sum of 3 quarters · filed 2012-08-10 | $134.31K derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | $38.92K 10-Q · filed 2012-05-15 | $53.70K derived: sum of 2 quarters · filed 2012-05-15 | $90.97K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $14.77K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $52.05K derived: sum of 2 quarters · filed 2012-04-16 | $107.31K 10-K · filed 2012-04-16 | |
| 2010-09-30 | $37.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $92.54K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $55.27K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |